{'fraction_non_alphanumeric': 0.01729106628242075, 'fraction_numerical': 0.004322766570605188, 'mean_word_length': 5.4953271028037385, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Combined use of automatic systems for treating patients with type 1 diabetes mellitus].

The efficacy of the combined consecutive use of the apparatus "Artificial Pancreas" (Biostator) and portable dosing apparatuses of insulin (Microjet) was investigated in 21 patients with type I diabetes mellitus in order to work out a method for glycemia correction. Preliminary results of the use of Biostator provided an opportunity for preparing an adequate scheme of insulin administration using microdosing apparatuses. The method made it possible to reduce the time for achieving compensation of the disease and attaining partial remission in patients with newly diagnosed type I diabetes mellitus.